Physician profile
Olivia Graza
NPI 1679348833
$1,068.55
in general payments reported to CMS, 2019-2025
14 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $722 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737 · Travel and Lodging: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.94 |
| Travel and Lodging | $331.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $546.57 | 2024 | |
| Virtus Pharmaceuticals LLC | $97.30 | 2024-2025 | Levorphanol Tartrate |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Saluda Medical Americas, INC. | $48.18 | 2025 | Evoke |
| Nalu Medical, INC. | $44.15 | 2024 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $41.76 | 2025 | Prospera |
| Globus Medical, INC. | $37.64 | 2025 | Senza |
| Nevro Corp. | $32.40 | 2024 | Senza |
| Tersera Therapeutics LLC | $28.40 | 2025 | Prialt |
| Djo, LLC | $26.74 | 2025 | Aircast |
| Curonix LLC | $21.39 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Merit Medical Systems INC | $21.13 | 2024 | Star Tumor Ablation System, Stabilit System |
| Forte Bio-Pharma LLC | $19.81 | 2025 | Prolate, Tanlor, Nalocet |
| Spinal Simplicity, LLC | $19.03 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Graza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.